Diagnostic Robotics is an Israeli health-AI company whose predictive models help health systems identify at-risk patients and intervene earlier.
Spun out of research on AI-driven triage, Diagnostic Robotics analyzes clinical and claims data to predict which patients are likely to deteriorate, be hospitalized or need targeted outreach. Its platform supports care management teams with risk stratification and automated engagement, and it has been deployed with large health insurers and providers, including national-scale programs. The company focuses on measurable outcomes: fewer admissions, better chronic-disease management.
Diagnostic Robotics works with payers and providers under enterprise agreements scoped to covered populations and modules.
Health insurers, hospital systems and public health organizations managing large populations and rising costs.
Diagnostic Robotics serves health systems managing population risk with limited care resources.
Deployments integrate claims and clinical data first; risk models then feed care-management dashboards your teams act on daily.
Fewer avoidable admissions and better chronic-disease management, with evidence trails for every prediction.
Deployments integrate claims and clinical data, calibrate risk models on the local population and feed care-management dashboards with ongoing analytic support.
Value depends on acting on risk lists, and healthcare data integration takes real time and governance effort.
Care teams say the risk stratification finally lets limited resources reach the members who need them.
Healthcare’s constraint is not data — it is attention. Diagnostic Robotics helps care teams direct limited effort toward the members whose trajectories are worsening. The technology is only half the program; the workflows it triggers are where outcomes come from.
Worsening-risk prediction only pays when outreach follows. Diagnostic Robotics suits health systems ready to close that loop with real workflows.
No. It is an enterprise healthcare platform engaged through commercial agreements.
Integration into health-system data environments is arranged per deployment with defined interfaces.
Against standard actuarial scoring, its clinical AI predicts individual deterioration events, enabling proactive intervention rather than retrospective reporting.